Your browser doesn't support javascript.
loading
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial.
Cowper, Patricia A; Sheng, Shubin; Lopes, Renato D; Anstrom, Kevin J; Stafford, Judith A; Davidson-Ray, Linda; Al-Khatib, Sana M; Ansell, Jack; Dorian, Paul; Husted, Steen; McMurray, John J V; Steg, P Gabriel; Alexander, John H; Wallentin, Lars; Granger, Christopher B; Mark, Daniel B.
Afiliação
  • Cowper PA; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Sheng S; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Lopes RD; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Anstrom KJ; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Stafford JA; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Davidson-Ray L; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Al-Khatib SM; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Ansell J; Department of Medicine, Hofstra Northwell School of Medicine, Hemstead, New York.
  • Dorian P; Division of Cardiology, University of Toronto, Toronto, Ontario, Canada.
  • Husted S; Aarhus University, Aarhus, Denmark.
  • McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland.
  • Steg PG; Université Paris-Diderot, Sorbonne Paris Cité, French Alliance for Cardiovascular Clinical Trials, Département Hospitalo-Universitaire Fibrosis, Inflammation, Remodeling, Assistance-Publique-Hôpitaux de Paris and Institut National de la Santé et de la Recherche Médicale U-1148, Paris, France7Nationa
  • Alexander JH; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Wallentin L; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Granger CB; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
  • Mark DB; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
JAMA Cardiol ; 2(5): 525-534, 2017 05 01.
Article em En | MEDLINE | ID: mdl-28355434
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Fibrilação Atrial / Varfarina / Custos de Cuidados de Saúde / Anos de Vida Ajustados por Qualidade de Vida / Acidente Vascular Cerebral / Inibidores do Fator Xa Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Cardiol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Fibrilação Atrial / Varfarina / Custos de Cuidados de Saúde / Anos de Vida Ajustados por Qualidade de Vida / Acidente Vascular Cerebral / Inibidores do Fator Xa Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Cardiol Ano de publicação: 2017 Tipo de documento: Article